▶ 調査レポート

エクセナチドの世界市場 2020年

• 英文タイトル:Global Exenatide Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。エクセナチドの世界市場 2020年 / Global Exenatide Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / GIR201114378資料のイメージです。• レポートコード:GIR201114378
• 出版社/出版日:GlobalInfoResearch / 2020年10月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、エクセナチドの世界市場を調査対象にし、エクセナチドの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(徐放性注射用懸濁液、速放性注射用懸濁液)、用途別分析(病院、ドラッグストア)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:AstraZeneca
・企業別売上、市場シェア
・エクセナチドの地域別市場分析
・エクセナチドの北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・エクセナチドのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・エクセナチドのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・エクセナチドの南米市場規模2015-2020:ブラジル、アルゼンチンなど
・エクセナチドの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・エクセナチドの種類別市場規模2015-2020:徐放性注射用懸濁液、速放性注射用懸濁液
・エクセナチドの用途別市場規模2015-2020:病院、ドラッグストア
・エクセナチドの世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The global Exenatide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Exenatide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Exenatide market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Exenatide market has been segmented into:
Extended-release injectable suspension
Fast release injectable suspension

By Application, Exenatide has been segmented into:
Hospital
Drug store

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Exenatide market presented in the report. This section sheds light on the sales growth of different regional and country-level Exenatide markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Exenatide market.

The report offers in-depth assessment of the growth and other aspects of the Exenatide market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Exenatide Market Share Analysis
Exenatide competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Exenatide sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Exenatide sales, revenue and market share for each player covered in this report.

The major players covered in Exenatide are:
AstraZeneca

レポート目次

1 Exenatide Market Overview
1.1 Product Overview and Scope of Exenatide
1.2 Classification of Exenatide by Type
1.2.1 Global Exenatide Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Exenatide Revenue Market Share by Type in 2019
1.2.3 Extended-release injectable suspension
1.2.4 Fast release injectable suspension
1.3 Global Exenatide Market by Application
1.3.1 Overview: Global Exenatide Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Exenatide Market by Regions
1.4.1 Global Exenatide Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Exenatide (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Exenatide Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Exenatide Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Exenatide Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Exenatide Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Exenatide Status and Prospect (2015-2025)
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Exenatide Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Exenatide Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Exenatide Players Market Share
3.2.2 Top 10 Exenatide Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Exenatide Revenue and Market Share by Regions
4.2 North America Exenatide Revenue and Growth Rate (2015-2020)
4.3 Europe Exenatide Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Exenatide Revenue and Growth Rate (2015-2020)
4.5 South America Exenatide Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Exenatide Revenue and Growth Rate (2015-2020)
5 North America Exenatide Revenue by Countries
5.1 North America Exenatide Revenue by Countries (2015-2020)
5.2 USA Exenatide Revenue and Growth Rate (2015-2020)
5.3 Canada Exenatide Revenue and Growth Rate (2015-2020)
5.4 Mexico Exenatide Revenue and Growth Rate (2015-2020)
6 Europe Exenatide Revenue by Countries
6.1 Europe Exenatide Revenue by Countries (2015-2020)
6.2 Germany Exenatide Revenue and Growth Rate (2015-2020)
6.3 UK Exenatide Revenue and Growth Rate (2015-2020)
6.4 France Exenatide Revenue and Growth Rate (2015-2020)
6.5 Russia Exenatide Revenue and Growth Rate (2015-2020)
6.6 Italy Exenatide Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Exenatide Revenue by Countries
7.1 Asia-Pacific Exenatide Revenue by Countries (2015-2020)
7.2 China Exenatide Revenue and Growth Rate (2015-2020)
7.3 Japan Exenatide Revenue and Growth Rate (2015-2020)
7.4 Korea Exenatide Revenue and Growth Rate (2015-2020)
7.5 India Exenatide Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Exenatide Revenue and Growth Rate (2015-2020)
8 South America Exenatide Revenue by Countries
8.1 South America Exenatide Revenue by Countries (2015-2020)
8.2 Brazil Exenatide Revenue and Growth Rate (2015-2020)
8.3 Argentina Exenatide Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Exenatide by Countries
9.1 Middle East & Africa Exenatide Revenue by Countries (2015-2020)
9.2 Saudi Arabia Exenatide Revenue and Growth Rate (2015-2020)
9.3 UAE Exenatide Revenue and Growth Rate (2015-2020)
9.4 Egypt Exenatide Revenue and Growth Rate (2015-2020)
9.5 South Africa Exenatide Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Exenatide Revenue and Market Share by Type (2015-2020)
10.2 Global Exenatide Market Forecast by Type (2019-2024)
10.3 Extended-release injectable suspension Revenue Growth Rate (2015-2025)
10.4 Fast release injectable suspension Revenue Growth Rate (2015-2025)
11 Global Exenatide Market Segment by Application
11.1 Global Exenatide Revenue Market Share by Application (2015-2020)
11.2 Exenatide Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Drug store Revenue Growth (2015-2020)
12 Global Exenatide Market Size Forecast (2021-2025)
12.1 Global Exenatide Market Size Forecast (2021-2025)
12.2 Global Exenatide Market Forecast by Regions (2021-2025)
12.3 North America Exenatide Revenue Market Forecast (2021-2025)
12.4 Europe Exenatide Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Exenatide Revenue Market Forecast (2021-2025)
12.6 South America Exenatide Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Exenatide Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Exenatide Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Exenatide by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Exenatide Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Exenatide Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AstraZeneca Corporate Information, Location and Competitors
Table 6. AstraZeneca Exenatide Major Business
Table 7. AstraZeneca Exenatide Total Revenue (USD Million) (2017-2018)
Table 8. AstraZeneca SWOT Analysis
Table 9. AstraZeneca Exenatide Product and Solutions
Table 10. AstraZeneca Exenatide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Global Exenatide Revenue (Million USD) by Players (2015-2020)
Table 12. Global Exenatide Revenue Share by Players (2015-2020)
Table 13. Global Exenatide Revenue (Million USD) by Regions (2015-2020)
Table 14. Global Exenatide Revenue Market Share by Regions (2015-2020)
Table 15. North America Exenatide Revenue by Countries (2015-2020)
Table 16. North America Exenatide Revenue Market Share by Countries (2015-2020)
Table 17. Europe Exenatide Revenue (Million USD) by Countries (2015-2020)
Table 18. Asia-Pacific Exenatide Revenue (Million USD) by Countries (2015-2020)
Table 19. South America Exenatide Revenue by Countries (2015-2020)
Table 20. South America Exenatide Revenue Market Share by Countries (2015-2020)
Table 21. Middle East and Africa Exenatide Revenue (Million USD) by Countries (2015-2020)
Table 22. Middle East and Africa Exenatide Revenue Market Share by Countries (2015-2020)
Table 23. Global Exenatide Revenue (Million USD) by Type (2015-2020)
Table 24. Global Exenatide Revenue Share by Type (2015-2020)
Table 25. Global Exenatide Revenue Forecast by Type (2021-2025)
Table 26. Global Exenatide Revenue by Application (2015-2020)
Table 27. Global Exenatide Revenue Share by Application (2015-2020)
Table 28. Global Exenatide Revenue Forecast by Application (2021-2025)
Table 29. Global Exenatide Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Exenatide Picture
Figure 2. Global Exenatide Revenue Market Share by Type in 2019
Figure 3. Extended-release injectable suspension Picture
Figure 4. Fast release injectable suspension Picture
Figure 5. Exenatide Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Drug store Picture
Figure 8. Global Exenatide Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Exenatide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Exenatide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Exenatide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Exenatide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Exenatide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Exenatide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Exenatide Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Exenatide Revenue Market Share in 2019
Figure 17. Global Top 10 Players Exenatide Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Exenatide Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Exenatide Revenue Market Share by Regions (2015-2020)
Figure 21. Global Exenatide Revenue Market Share by Regions in 2018
Figure 22. North America Exenatide Revenue and Growth Rate (2015-2020)
Figure 23. Europe Exenatide Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Exenatide Revenue and Growth Rate (2015-2020)
Figure 25. South America Exenatide Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Exenatide Revenue and Growth Rate (2015-2020)
Figure 27. North America Exenatide Revenue Market Share by Countries (2015-2020)
Figure 28. North America Exenatide Revenue Market Share by Countries in 2019
Figure 29. USA Exenatide Revenue and Growth Rate (2015-2020)
Figure 30. Canada Exenatide Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Exenatide Revenue and Growth Rate (2015-2020)
Figure 32. Europe Exenatide Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Exenatide Revenue Market Share by Countries in 2019
Figure 34. Germany Exenatide Revenue and Growth Rate (2015-2020)
Figure 35. UK Exenatide Revenue and Growth Rate (2015-2020)
Figure 36. France Exenatide Revenue and Growth Rate (2015-2020)
Figure 37. Russia Exenatide Revenue and Growth Rate (2015-2020)
Figure 38. Italy Exenatide Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Exenatide Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Exenatide Revenue Market Share by Countries in 2019
Figure 41. China Exenatide Revenue and Growth Rate (2015-2020)
Figure 42. Japan Exenatide Revenue and Growth Rate (2015-2020)
Figure 43. Korea Exenatide Revenue and Growth Rate (2015-2020)
Figure 44. India Exenatide Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Exenatide Revenue and Growth Rate (2015-2020)
Figure 46. South America Exenatide Revenue Market Share by Countries (2015-2020)
Figure 47. South America Exenatide Revenue Market Share by Countries in 2019
Figure 48. Brazil Exenatide Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Exenatide Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Exenatide Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Exenatide Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Exenatide Revenue and Growth Rate (2015-2020)
Figure 53. UAE Exenatide Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Exenatide Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Exenatide Revenue and Growth Rate (2015-2020)
Figure 56. Global Exenatide Revenue Share by Type (2015-2020)
Figure 57. Global Exenatide Revenue Share by Type in 2019
Figure 58. Global Exenatide Market Share Forecast by Type (2021-2025)
Figure 59. Global Extended-release injectable suspension Revenue Growth Rate (2015-2020)
Figure 60. Global Fast release injectable suspension Revenue Growth Rate (2015-2020)
Figure 61. Global Exenatide Revenue Share by Application (2015-2020)
Figure 62. Global Exenatide Revenue Share by Application in 2019
Figure 63. Global Exenatide Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospital Revenue Growth Rate (2015-2020)
Figure 65. Global Drug store Revenue Growth Rate (2015-2020)
Figure 66. Global Exenatide Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Exenatide Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Exenatide Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Exenatide Revenue Market Forecast (2021-2025)
Figure 70. Europe Exenatide Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Exenatide Revenue Market Forecast (2021-2025)
Figure 72. South America Exenatide Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Exenatide Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel